Skip to content

Gilead issues tenofovir/ddI/3TC warning for European doctors - follows US warning last week

New form of liposuction able to reduce buffalo hump - at least in the short term

One in four UK HIV diagnoses are missed says BHIVA

Australian therapeutic vaccine shows promise in treatment interruption

HAART continues to improve survival, but not all HIV risk groups benefit equally

Global Fund approves $359 million for AIDS

GSK gives pan-Africa license to South African firm

Less than 40% of HIV-positive Swiss cohort have CD4 cell count above 500 after four years of HAART

Don't use tenofovir, ddI, 3TC combination warns Gilead